It should be noted that neuroprotective effects of fisetin may be also explained by its binding with AD-associated amyloid-binding alcohol dehydrogenase, acetylcholinesterase, and β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) enzymes, as previously predicted by molecular docking [22]. The gene discussed is BACE1; the disease is Alzheimer disease.